Catalyst Event
Innovent Biologics Inc (1801) · Other
From Akros SCHK HK-U.S. Biotech Index (ASHUBIO)
6/5/2026, 12:00:00 AM
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
Korean Translation
2026년 6월 5일부터 8일까지 ADA 과학 세션에서 비만 파이프라인 데이터 발표가 예정되어 있으며, 이 낮은 영향력의 행사가 예정됨
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date of 2026-06-01 for final and special dividends, scheduled. (Estimated Low impact as dividend is standard).
6/1/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Earnings Release
Q1 2026 earnings release scheduled. Analysts forecast revenue of 7.52B HKD. Estimated Medium importance as earnings results typically drive significant price movement scheduled.
5/27/2026, 12:00:00 AM
Amgen Inc (AMGN) · Other
The ex-dividend date for Amgen's Q2 2026 dividend of $2.52 per share is scheduled for May 15, 2026. The dividend is payable on June 5, 2026, to shareholders of record on the ex-date scheduled.
5/15/2026, 12:00:00 AM